Everolimus
Product Images NDC 49884-128

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 49884-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Everolimus Tablets 1)

Chemical structure diagram of Everolimus, showing its molecular framework with various functional groups and stereochemistry, consistent with its identity as an active pharmaceutical ingredient. The image includes rings, carbon chains, oxygen, nitrogen atoms, and hydroxyl groups.*

FDA Label Image

Carton (7.5 mg)

Everolimus Tablets, 7.5 mg packaging label for 28 tablets, containing 4 individual blister cards of 7 tablets each. The label shows the dosage strength prominently as 7.5 mg everolimus per tablet. The product is labeled as Rx only and manufactured by Par Pharmaceutical, with instructions for storage and a contact phone number for more information. The National Drug Code (NDC) is 49884-127-91.*

FDA Label Image

Everolimus Tablets 11

Blister card packaging label for Everolimus Tablet 10 mg by Par Pharmaceutical, showing multiple tablet cavities with eight labeled tablets and three empty cavities. Each blister cavity is individually labeled with the product name, strength (10 mg), and manufacturer information from PAR PHARMACEUTICAL, Chestnut Ridge, NY 10977, including barcodes and lot/expiration date areas.*

FDA Label Image

Everolimus Tablets 12

Everolimus Tablets, 10 mg packaging label from Par Pharmaceutical. The carton contains 28 tablets, divided into 4 individual blister cards with 7 tablets each. The label includes storage instructions, dosage guidance to see package insert, and warnings to keep out of reach of children. The NDC number is 49884-128-91.*

FDA Label Image

Figure 1 (Everolimus Tablets 2)

A Kaplan-Meier survival curve graph depicting progression-free survival probability (%) over time in months. It compares Everolimus 10 mg combined with exemestane versus placebo combined with exemestane. The graph shows survival probability declining over time, with Everolimus plus exemestane demonstrating higher progression-free survival compared to placebo.*

FDA Label Image

Figure 2 (Everolimus Tablets 3)

A Kaplan-Meier survival curve comparing Everolimus Tablets and placebo over time (months) with probability (%) on the Y-axis. The graph includes data points for censoring times, showing Everolimus (N=207) with a solid line and placebo (N=203) with a dotted line. Statistics on hazard ratio, confidence interval, and median survival times are provided.*

FDA Label Image

Figure 4 (Everolimus Tablets 4)

Kaplan-Meier survival probability curve comparing Everolimus (N=277) versus placebo (N=139) over time in months. The graph includes hazard ratio, confidence interval, and p-value, with markers for censoring times for both groups. The chart shows Everolimus with a median survival of 4.9 months and placebo with 1.9 months.*

FDA Label Image

Blister (2.5 mg)

Multiple pharmacy vial labels for Everolimus Tablet 2.5 mg, Rx only, labeled by Par Pharmaceutical, Chestnut Ridge, NY. Each label includes storage instructions at 25°C with allowed temperature excursions, barcodes, and lot numbers.*

FDA Label Image

Carton (2.5 mg)

Everolimus Tablets, 2.5 mg packaging label by Par Health USA, LLC. The carton contains 28 tablets, arranged as 4 blister cards of 7 tablets each. The label prominently shows the dosage strength as 2.5 mg of everolimus per tablet, includes the NDC 49884-119-91, and states Rx only. Storage instructions and manufacturer details are also visible.*

FDA Label Image

Blister (5 mg)

Label for Everolimus Tablet 5 mg by Par Pharmaceutical, showing multiple identical sections with storage instructions to keep at 25°C (77°F) with excursions permitted between 15° to 30°C, and protection from light and moisture. Each section includes the Rx only designation, the manufacturer's location in Chestnut Ridge, NY, and a barcode.*

FDA Label Image

Carton (5 mg)

Outer carton packaging for Everolimus Tablets, 5 mg, labeled for 28 tablets packed as four blister cards of seven tablets each. The label shows the NDC 49884-125-91 and indicates prescription use only. Manufactured by Par Pharmaceutical, with storage instructions and contact information for more details.*

FDA Label Image

Blister (7.5 mg)

Label for Everolimus Tablet 7.5 mg by Par Pharmaceutical, part of Par Health USA, LLC. Instructions specify storage at 25°C (77°F) with allowed excursions from 15° to 30°C (59° to 86°F). Store in original container protected from light and moisture. The label includes a barcode and Rx Only designation, repeated eight times in a sheet layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.